<br>The antibiotic R&D landscape in Japan</br><em> – by Norio Ohmagari</em>
25 November 2020

The antibiotic R&D landscape in Japan – by Norio Ohmagari

more
<br>Tackling the drug-resistance pandemic – 2020 and beyond</br><em> – by Laura J.V. Piddock</em>
23 November 2020

Tackling the drug-resistance pandemic – 2020 and beyond – by Laura J.V. Piddock

more
<br>Why are new antibacterials failing as commercial products?</br><em> – by Patricia A. Bradford</em>
19 November 2020

Why are new antibacterials failing as commercial products? – by Patricia A. Bradford

more
<br>COVID-19: Coinfection, secondary bacterial infections and AMR in India</br><em> – by Venkatasubramanian Ramasubramanian</em>
12 November 2020

COVID-19: Coinfection, secondary bacterial infections and AMR in India – by Venkatasubramanian Ramasubramanian

more
<br>Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic</br><em> – by Markus Heep, Esther Bettiol, Tanyaporn Wansom and Hilary Johnstone </em>
15 October 2020

Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic – by Markus Heep, Esther Bettiol, Tanyaporn Wansom ...

more
<br>A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need</br><em> – by John Rex</em>
6 October 2020

A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need ...

more
<br>Why we need a new access model for antibiotics</br><em> – by Yann Ferrisse and Fernando Pascual Martinez</em>
1 October 2020

Why we need a new access model for antibiotics – by Yann Ferrisse and Fernando Pascual Martinez

more
<br>Moving from paper to action – The status of National AMR Action Plans in African countries</br><em> – by Mirfin Mpundu</em>
25 September 2020

Moving from paper to action – The status of National AMR Action Plans in African countries – by Mirfin Mpundu

more
<br>Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them</br><em> – by Jack Stone and Maria Laura Ciusa</em>
5 August 2020

Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them – by Jack Stone and Maria Laura ...

more
<br>Getting the most out of antimicrobial surveillance</br><em> – by Mariana Castanheira</em>
28 May 2020

Getting the most out of antimicrobial surveillance – by Mariana Castanheira

more
© All Rights Reserved
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top